Delivery Order SPE2DB20D2014-SPE2DB24FC33T

Award Date 6/27/24
Potential Completion Date 6/28/24
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of 4,564,817,027 units of the pharmaceutical product Ondansetron ODT 8 mg Tablet in 30-count packages. The contract has a ceiling value of $6,154.92 and is a delivery order with a firm fixed price. The contracting agency is the Defense Logistics Agency (DLA) Troop Support Medical, which provides logistics and acquisition services for the U.S. Department of Defense. Amerisourcebergen...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,008,244 units of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $11,330.40 firm fixed price delivery order has a June 27, 2024 completion date. As a subsidiary of one of the largest pharmaceutical distributors, Amerisourcebergen leverages its extensive supply chain to fulfill government contracts, with a focus on serving the Department of Defense (DoD)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office division. The $19,006.49 contract is for the provision of 4,565,032,100 units of the pharmaceutical product Ondansetron ODT 4 mg tablets. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a...
This federal contract award to Amerisourcebergen Drug Corp is for the delivery of 4,564,943,555 units of the pharmaceutical drug Ondansetron ODT 4 mg tablets. The $24,544.20 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract has an ultimate completion date of June 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,707.55 firm fixed price delivery order is for the supply of 4,566,197,426 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of October 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
The U.S. Defense Logistics Agency (DLA) awarded a $14,550.99 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of 4,564,299,405 units of the pharmaceutical product Ondansetron ODT 8 mg Tablets. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. The IDC enables DLA to efficiently procure essential...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564793392 Ondansetron ODT 4 mg tablets. The contract, valued at $1,388.49, was awarded on June 3, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 4, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not associated with a set-aside designation. Amerisourcebergen is a major supplier of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation, is for the delivery of 4,565,047,457 units of the prescription medication Ondansetron ODT 4 mg tablets. The $1,251.66 firm fixed-price contract was awarded on July 1, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 2, 2024. This appears to be a delivery order under...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $5,001.12, is for the delivery of 4,564,560,290 units of Ondansetron ODT 4 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide 4,564,792,670 units of the medication Ondansetron ODT 4 mg Tablet 30s. The $11,305.60 Firm Fixed Price Delivery Order has a completion date of June 4, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC33T
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,014,184 units of the pharmaceutical product Ondansetron ODT 4 MG Tablet 30S. The $4,583.28 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency responsible for providing logistics and acquisition support to the U.S. Armed Forces. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for delivering a range of pharmaceutical and medical products to DLA facilities worldwide. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis. This award highlights Amerisourcebergen's expertise in efficiently managing the complex logistics of supplying critical medical products to government agencies, with a focus on serving the Department of Defense and Veterans Affairs healthcare systems.

Generated 9/26/24, 9:34 AM